Financière de Tubize SA/€TUB

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Financière de Tubize SA

Financière de Tubize SA is a Belgian holding company established in 1928, serving as the reference shareholder of UCB, a global biopharmaceutical company. Its sole investment is a significant stake in UCB, focusing on long-term value creation through active participation in UCB's strategic decisions. Headquartered in Brussels, Belgium, the company embodies strong family and entrepreneurial values, uniting descendants of UCB's founder, Emmanuel Janssen, and like-minded investors. This strategic positioning provides UCB with the stability necessary for sustained growth and investment in new products for patients with serious illnesses.

Ticker

€TUB
Sector

Primary listing

BSE

Employees

3

TUB Metrics

BasicAdvanced
€7.5B
81.26
€2.08
0.37
€0.73
0.43%

Bulls say / Bears say

Profit growth: For FY2024, Tubize posted a 2.2% increase in profit to €90.1 million, reflecting value gains from its holding in UCB. (GlobeNewswire)
Dividend uplift: The board has proposed a gross dividend of €1.04 per share for FY2024, up 7.2% year-on-year, demonstrating robust cash flow and ongoing commitment to shareholder returns. (GlobeNewswire)
Debt reduction: Outstanding bank borrowings fell from €79.2 million to €41.3 million in 2024, strengthening Tubize’s financial flexibility and reducing leverage. (GlobeNewswire)
Single-asset concentration: Financière de Tubize’s only investment is its 36.27% stake in UCB, making its revenue and net asset value highly dependent on UCB’s operational and market performance. (FinancialReports.eu)
Leverage risk: As of end-2024, outstanding bank borrowings were €41.3 million. Any increase in interest rates could raise financing costs and put pressure on Tubize’s liquidity. (GlobeNewswire)
Dividend dependency: The proposed gross dividend of €1.04 per share for FY2024 (up 7.2%) depends on UCB’s profitability and approval at the AGM, highlighting Tubize’s reliance on UCB’s strategic decisions and financial health. (GlobeNewswire)
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €TUB

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs